Premenstrual Dysphoric Disorder Awareness and Research Act of 2026

The Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 would direct federal resources toward the study and public understanding of Premenstrual Dysphoric Disorder (PMDD). As a standard piece of legislation, it would require the President's signature to become law. The bill aims to address the medical and social challenges associated with this severe form of premenstrual syndrome by authorizing new research initiatives and educational campaigns.

If enacted, the bill would likely impact citizens by fostering a better understanding of PMDD among healthcare providers and the general public. This could lead to earlier diagnoses, more effective treatment protocols, and increased support for individuals living with the condition. By prioritizing PMDD within federal health agencies, the legislation seeks to close gaps in medical knowledge and improve the quality of life for those affected by this hormonal mood disorder.